Browse Pet Safety Reports
18,059 FDA adverse event reports for pets.
FDA Veterinary Adverse Event Database
Browse 18,059 adverse event reports collected by the FDA's Center for Veterinary Medicine. Each report includes the animal species, breed, drug or product involved, observed reactions, and outcome. Reports flagged as "serious" involve death, life-threatening conditions, or hospitalization. Use the filters to narrow results by species, outcome severity, or keyword. Note that a higher number of reports does not necessarily indicate a less safe product, widely prescribed drugs naturally accumulate more reports.
Pet Adverse Event Reports
Browse 18,059 FDA veterinary adverse event reports for Horse.
| Date | Species | Breed | Drug | Reaction | Outcome |
|---|---|---|---|---|---|
| Nov 13, 2023 | Horse | Thoroughbred | Flunixin Meglumine Injectable | Pruritus; Pale mucous membrane; Lying down; Uncomfortable; Discomfort NOS; An... | Ongoing |
| Nov 13, 2023 | Horse | Thoroughbred | Ceftiofur Crystalline Free Acid | Pruritus; Pale mucous membrane; Lying down; Uncomfortable | Ongoing |
| Nov 13, 2023 | Horse | Horse (unknown) | Ketamine Hydrochloride | Lack of efficacy - NOS | Outcome Unknown |
| Nov 12, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 10, 2023 | Horse | Quarter Horse | Ceftiofur Sodium | Hives (see also Skin) | Recovered/Normal |
| Nov 9, 2023 | Horse | Quarter Horse | Ciclesonide | Behavioural disorder NOS | Outcome Unknown |
| Nov 9, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 9, 2023 | Horse | Horse (unknown) | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Nov 8, 2023 | Horse | Thoroughbred | Ceftiofur Sodium | Enlarged lymph node (localised); Fever; Neutrophilia; Decreased red blood cel... | Ongoing |
| Nov 8, 2023 | Horse | Quarter Horse | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Nov 7, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 7, 2023 | Horse | Arab | Pergolide Mesylate | Behavioural disorder NOS | Outcome Unknown |
| Nov 7, 2023 | Horse | Saddlebred - American | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 6, 2023 | Horse | Arab | Pergolide Mesylate | Ataxia; Anorexia | Outcome Unknown |
| Nov 6, 2023 | Horse | Horse (other) | Ivermectin; Praziquantel | Application site irritation; Oral ulceration | Recovered/Normal; Outcome Unknown |
| Nov 6, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Aneurism | Outcome Unknown |
| Nov 6, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Recovered/Normal |
| Nov 5, 2023 | Horse | Quarter Horse | Flunixin Meglumine Injectable | Not drinking; Discoloured urine; Injection site hair loss; Rolling; Drooling;... | Died |
| Nov 3, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Behavioural disorder NOS; Decreased appetite; Increased bowel movements (freq... | Outcome Unknown |
| Nov 3, 2023 | Horse | Thoroughbred | Detomidine Hydrochloride | Lack of efficacy - NOS | Recovered/Normal |
| Nov 3, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Nov 3, 2023 | Horse | Friesian | Flunixin Meglumine Injectable | Seizure NOS; Death; Medication error NOS | Died |
| Nov 3, 2023 | Horse | Arab | Ivermectin; Praziquantel | Ataxia; Pale mucous membrane; Gut sounds decreased; Other abnormal test resul... | Recovered/Normal |
| Nov 2, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Nov 2, 2023 | Horse | Quarter Horse | Ivermectin; Praziquantel | Application site oedema; Face and neck swelling (see also Skin); Swollen gum | Recovered/Normal |
| Nov 2, 2023 | Horse | Horse (unknown) | Polysulfated Glycosaminoglycan | Injection site oedema | Recovered/Normal |
| Nov 2, 2023 | Horse | Unknown | Sodium Hyaluronate | Joint swelling | Recovered/Normal |
| Nov 2, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Death; Colic | Died |
| Nov 2, 2023 | Horse | Warmblood (unspecified) | Polysulfated Glycosaminoglycan | Injection site swelling | Recovered/Normal |
| Nov 1, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Death | Died |
| Nov 1, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Lack of efficacy - NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Horse (unknown) | Pergolide Mesylate | Behavioural disorder NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Percheron, Pura Raza EspaƱo... | Pergolide Mesylate | Digestive tract disorder NOS | Outcome Unknown |
| Nov 1, 2023 | Horse | Thoroughbred | Polysulfated Glycosaminoglycan | Injection site swelling | Outcome Unknown |
| Oct 31, 2023 | Horse | Quarter Horse | Hyaluronate Sodium | Lack of efficacy - NOS | Ongoing |
| Oct 31, 2023 | Horse | Rocky Mountain Horse | Pergolide Mesylate | Gastric ulcer | Recovered/Normal |
| Oct 31, 2023 | Horse | Belgian Draft, also called ... | Vit E/ Selenite Inj Solution | Anaphylaxis; Ptyalism; Tachypnoea; Cyanotic mucous membranes; Heavy sweating;... | Recovered/Normal |
| Oct 30, 2023 | Horse | Quarter Horse | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Oct 30, 2023 | Horse | Oldenburg | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Oct 28, 2023 | Horse | Arab | Pergolide Mesylate | Partial anorexia; Diarrhoea | Recovered/Normal |
| Oct 28, 2023 | Horse | Horse (other) | Altrenogest Oily Solution | Lack of efficacy - NOS | Recovered/Normal |
| Oct 27, 2023 | Horse | Horse (unknown) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Oct 27, 2023 | Horse | Paint | Praziquantel;Moxidectin | Hives (see also Skin); Allergic oedema | Recovered/Normal |
| Oct 27, 2023 | Horse | Warmblood - Dutch | Omeprazole | INEFFECTIVE, GASTRIC ULCER(S); Partial lack of efficacy; Underdose | Outcome Unknown |
| Oct 27, 2023 | Horse | Horse (other) | Ivermectin; Praziquantel | Hypersalivation; Tachypnoea; Pale mucous membrane; Application site swelling;... | Recovered/Normal |
| Oct 27, 2023 | Horse | Quarter Horse | Pentosan Polysulfate Sodium | Injection site swelling; Hyperthermia; Lethargy (see also Central nervous sys... | Outcome Unknown |
| Oct 26, 2023 | Horse | Haflinger | Omeprazole | Hypocalcaemia; Neutropenia; Elevated creatine-kinase (CK); Lymphopenia; Neutr... | Recovered/Normal |
| Oct 26, 2023 | Horse | Warmblood (unspecified) | Omeprazole | Lack of efficacy - NOS | Ongoing |
| Oct 26, 2023 | Horse | Pony (unspecified) | Omeprazole | Lack of efficacy - NOS | Outcome Unknown |
| Oct 25, 2023 | Horse | Oldenburg | Omeprazole | Lack of efficacy - NOS | Ongoing |
Frequently Asked Questions
Contact your veterinarian immediately. If the reaction is severe, difficulty breathing, seizures, collapse, or severe swelling, seek emergency veterinary care right away. After your pet is stabilized, report the adverse event to the FDA through safetyreporting.hhs.gov or by calling 1-888-FDA-VETS (1-888-332-8387). Reporting helps the FDA identify safety issues that can lead to label changes or product recalls.
Dogs account for the majority of adverse event reports, followed by cats. This reflects both the larger pet population and wider range of medications for these species. Flea and tick products, pain medications (NSAIDs), and heartworm preventives are among the product categories with the highest report counts across all species.
Not necessarily. A drug used by millions of pets will have more reports in absolute numbers than a niche product, even if the actual rate of adverse events is lower. The FDA uses these reports as one of many tools to evaluate drug safety, looking for patterns and statistical signals rather than raw counts alone. Always consult your veterinarian before changing any medication.